Open Access Open Access  Restricted Access Access granted  Restricted Access Subscription or Fee Access

Vol 28, No 14 (2021)

Articles

News of medicine

- -.
Pharmateca. 2021;28(14):6-9
pages 6-9 views

Current trends in the study of the pathogenesis of acne

Sidorenko E.E., Lvov A.N.

Abstract

Acne (acne vulgaris) is a chronic inflammatory disease of the pilosebaceous follicle, the characteristic manifestations of which include open and closed comedones, as well as papules, pustules, nodes. Acne is diagnosed in 9.4% of the general population and belongs to multifactorial dermatoses, accompanied by excessive production of sebum, follicular hyperkeratosis of the excretory ducts of the sebaceous glands, followed by their occlusion, hypercolonization of Cutibacterium acnes and an inflammatory reaction. The study of the pathogenesis of the disease is relevant, because allows to expand the range of drugs for treatment and affect all links of pathogenesis thoroughly and comprehensively. The literature review presents the main pathogenetic aspects of the development of acne vulgaris.
Pharmateca. 2021;28(14):10-14
pages 10-14 views

Skin lesions in endocrine diseases

Ladygina D.O., Zheleznyakova A.V., Kruglova L.S.

Abstract

Endocrine diseases are accompanied by diverse skin manifestations, which can vary from general signs such as acne, hirsutism, hyper- or hypopigmentation, to extremely rare dermatoses. These symptoms can significantly affect the quality of life of patients. This article presents the most common skin lesions in different endocrinopathies: disorders of the thyroid gland, hypothalamic-pituitary axis, pancreas, adrenal glands, androgenic axis, as well as hereditary endocrine syndromes. Skin manifestations can be the first and isolated signs of the development of endocrine pathology; therefore, doctors of various specialties, namely dermatologists and therapists, need to know the skin symptoms of endocrine disorders for prompt diagnosis and determination of the optimal patient management tactics in cooperation with an endocrinologist.
Pharmateca. 2021;28(14):15-21
pages 15-21 views

The effectiveness of early administration of interleukin-17 blockers in the treatment of axial lesions in psoriatic arthritis

Kruglova L.S., Pereverzina N.O.

Abstract

Currently, studies on evaluation of the effectiveness of netakimab not only in psoriasis and psoriatic arthritis, but also in axial spondy-loarthritis are underway. Research results confirm the effectiveness of the drug in enthesitis, dactylitis, axial lesions. In this report, we present the clinical experience of using netakimab in the treatment of severe psoriasis vulgaris, inverse psoriasis and psoriatic onychodystrophy, as well as its effectiveness in the early manifestations of axial lesions of psoriatic arthritis.
Pharmateca. 2021;28(14):22-26
pages 22-26 views

Pseudomonas skin infection: a brief literature review and authors’ own experience

Yakovlev A.B., Golanova O.A., Musa M.K., Mysina S.V., Zholinskaya Y.Y.

Abstract

Pseudomonas aeruginosa is one of the most dangerous opportunistic infections. Among the skin manifestations, it most often leads to the development of diseases such as Fournier’s gangrene, ecthyma gangrenosum, and causes the formation of chronic wounds. Due to the resistance of P. aeruginosa to various antibacterial drugs, the treatment of pseudomonas infection continues to be a difficult task for doctors around the world. A clinical case of a patient with a diagnosis of pseudomonas skin infection, generalized papulopustular form, ecthyma of the left leg and foot is discussed.
Pharmateca. 2021;28(14):27-33
pages 27-33 views

Malignant melanoma detected during follow-up: literature review and cases report

Sergeev Y.Y., Beinusov D.S., Mordovtseva V.V., Sergeev V.Y.

Abstract

The article discusses the possibility of timely diagnosis of malignant melanoma by assessing changes in the dermatoscopic picture of formations during follow-up. An analysis of 23 cases from authors’ own practice, identified mainly in patients at risk, is given. The age of the patients varied from 28 to 70 years, mean age 36.7±10.5 years. Follow-up of pigmented lesions before making a decision on excision was performed out for 3-24 months, on average - 10.5±5.4 months. Changes in the dermatoscopic picture were manifested by an asymmetric increase of the lesion and/or a change of its shape (43.5%), the appearance of a new color (69.6%), the formation of an atypical dermatoscopic structure (65.2%), a change in the pattern of the pigment network (56.5 %), modification of the dermatoscopic model of the structure (21.7%), partial regression of formation (4.3%). The mean diameter of the lesions during the follow-up period increased from 4.2±2.2 to 5.4±2.3 mm, the lesion value of the total dermoscopic score of the ABCD rule increased from 3.4±0.9 to 4.6±1.2 points (P<0.05). Histological examination diagnosed melanoma in situ in 52.2% of cases, in the rest - microinvasive melanoma (Clark level II) with Breslow thickness range from 0.2 to 0.5 mm.
Pharmateca. 2021;28(14):34-41
pages 34-41 views

Pruritus in dermatovenerology: psychosomatic aspects and new targets for therapy

Michenko A.V., Romanov D.V., Lvov A.N.

Abstract

Chronic itching is one of the most severe subjective symptoms, most often observed in certain skin diseases. At the same time, it is known that the itching can arise or worsen against the background of stressful events or within the framework of a number of psychosomatic and mental disorders. This article provides an overview of the factors provoking itching, and discusses new directions for the development of topical and systemic antipruritic drugs.
Pharmateca. 2021;28(14):42-46
pages 42-46 views

Facial rejuvenation with thread lift

Agapova M.A.

Abstract

Currently, there is a wide range of procedures, manipulations and substances designed to the prevention of age-related changes in the skin of patients in the arsenal of a dermatocosmetologist. Our article provides an overview of one of the most promising areas -thread lift.
Pharmateca. 2021;28(14):47-51
pages 47-51 views

Instrumental techniques as an effective method for correcting stretch marks

Petriy M.A., Manturova N.E., Shatokhina E.A.

Abstract

Stretch marks are linear areas of cutaneous atrophy, localized in places of greatest stretch of the skin. The presence of linear atrophies is a cosmetic defect that can cause significant psychological discomfort and reduce the quality of life of patients. In this regard, aesthetic correction of stretch marks is an urgent problem in dermatocosmetology. This article provides a review of the literature on modern methods of treating stretch marks. The principles of the impact of instrumental correction techniques and data from clinical trials are discussed.
Pharmateca. 2021;28(14):52-56
pages 52-56 views

Evaluation of the effectiveness of the combined use of photodynamic therapy and platelet-rich plasma in the genitourinary syndrome of menopause

Surkichin S.I., Avin M., Mayorov R.Y.

Abstract

Background. Menopause is a normal physiological event for middle-aged women. In about 50% of cases, the genitourinary syndrome of menopause (GSM) develops which significantly impairs the quality of life and definitely requires treatment. In recent years, photodynamic therapy (PDT) has been actively used to correct involutive skin changes, and the PRP-therapy method, the use of autologous platelet-rich blood plasma, is used as the advanced methods of rejuvenation. The effectiveness of PRP therapy looks promising, and the risks of this procedure with correct use are minimal. Objective. Evaluation of the efficacy and safety of PDT in combination with PRP in the treatment of GSM. Methods. This study included 15 patients diagnosed with genitourinary syndrome of menopause (involutive changes in the vulva). PDT procedures (photosensitizer chlorin E6 in the form of 1% gel was used) and plasmotherapy were performed only 10 times (each type of procedure 5 times) alternately once a week. The PDT AFS «Harmony» device (wavelength - 660 nm) was used as a radiation source. To assess the effectiveness of this therapy, the following scales were used: VHI (vaginal health index), VAS (visual analogue scale), and DLQI (Dermatology Life Quality Index). We also developed a scale for assessing VICV (visual involutive changes of the vulva) with assessment of 7 indicators: color/depigmentation, desquamation, skin texture to the touch, vascular pattern, hair-covering in the labia majora, flattening and wrinkling of the skin, cracks/erosion. Results. After alternating the course of PDT procedures with PRP-therapy, the patients noted a significant regression of itching, which completely disappeared in 11 patients; in the rest it significantly decreased. The symptoms of dryness completely disappeared in 6 patients, and decreased to insignificant value in the rest. After the completion of the course of procedures, a decrease in skin dryness on average up to 3 points was noted. Itching completely regressed in 6 out of 9 patients. Dyspareunia decreased significantly in 4 patients and disappeared completely in 6 patients. Significant changes were also observed when assessing the VHI in relation to the integrity of the epithelium (on average 4.93 points), indicators of moisture and transudate (4.73 each) and Ph-metry (4.4 points). The elasticity indicators did not change compared to the initial values. No serious side effects were detected during the entire period of treatment and after it. Conclusion. The use of PDT in combination with PRP-therapy in this study showed high efficacy in the form of a significant regression of the main complaints, such as itching and dryness, as well as an improvement in visual indicators of changes in the vulvar area. These procedures are safe in the treatment of GSM (no complications were observed during and after therapy). The new developed VICV scale will provide a more effective approach to the diagnosis of involutive changes in the vulva, as well as allow to prescribe the correct therapy depending on the severity of symptoms.
Pharmateca. 2021;28(14):57-62
pages 57-62 views

New potentials for the correction of non-neoplastic melanin hyperpigmentation

Kruglova L.S., Avagumyan M.A.

Abstract

Background. Hyperpigmentation is one of the most common reasons for seeking medical attention in aesthetic medicine. The main reasons for the formation of hyperpigmentation include primarily genetic, endocrine factors, and ultraviolet radiation, or their combination. Hyperpigmentation refers to aesthetic defects and can significantly reduce the quality of life of patients, especially when localized in open areas, which makes it relevant to study the effectiveness of new methods of therapy. Methods. The study included 36 patients with melasma, or post-inflammatory hyperpigmentation (PIH). All patients used Eucerin AntiPigment dermatocosmetics for 12 weeks. Efficacy was assessed using mexametry, IGA (Investigator’s Global Assessment) and DLQI (Dermatology Life Quality Index) clinical indices. Results. According to mexametry, all patients showed positive dynamics. The mexametry index decreased on average by 91.2% in patients with melasma and by 89.8% with PIH. The mean IGA and DLQI scores in patients with melasma decreased by 91.2 and 77.2% and in patients with PIH - by 89.8 and 74.3%. Conclusions. The use of Eucerin Anti-Pigment dermatocosmetics is effective in reducing hyperpigmentation and preventing its reappearance. Improvement is noted already after 2 weeks of use with further continuous improvement. The use of Eucerin Anti-Pigment is highly safe and well tolerated.
Pharmateca. 2021;28(14):63-69
pages 63-69 views

Change in the epidermal and dermal thickness as a result of photodynamic therapy using chlorin E6

Surkichin S.I., Kholupova L.S.

Abstract

Background. Due to the active rhythm of life and the increase in life expectancy, the demand for non-injection methods for correcting age-related skin changes is growing. Photodynamic therapy (PDT) methods, in particular, with the use of chlorin E6 derivatives, are increasingly used in cosmetology clinics. Objective. Evaluation of the effect of PDT with the use of chlorin E6-based photosensitizers and light radiation with a wavelength of 410 and 630 nm on the thickness of the epidermis and dermis of the face immediately after treatment, as well as in the long-term period. Methods. The epidermal and dermal thickness in the facial area was determined in women aged 35 to 45 before therapeutic exposure (course of PDT procedures using chlorin E6 once a week No. 5) - immediately after, and after 3 and 6 months, compared with the control group aged 25 to 35. Results. The epidermal thickness at the end of the course of treatment increased by 12%, and the dermal thickness - by 9.2%, after 3 months - by 21.2 and 20.7%, respectively, and after 6 months - by 23 and 24.7%, respectively. As a result of PDT, the indicators in the 35-45-year-old group became comparable to those in the 25-35-year-old control group. Conclusion. The data obtained indicate an increase in the epidermis and dermal thickness as a result of PDT using chlorin E6 and make it possible to recommend this method for the correction and prevention of involutive skin changes.
Pharmateca. 2021;28(14):70-73
pages 70-73 views

Evaluation of the of the effectiveness of burn scars correction using the Er:YAG laser

Bondarenko V.V., Shvidun D.V., Batinkina E.A.

Abstract

Background. Treatment of burn scars is one of the urgent problems of modern medicine, which requires a competent and comprehensive approach. Medical tactics are determined by the age of existence, variety, size, the presence of adverse factors and complications caused by previous treatment. Objective. Evaluation of the efficiency of laser correction of burn scars using an Er:YAG laser (2936 nm) with an SMA module (6 mm). Methods. 112 women aged 16-50 years were followed-up observation on an outpatient basis. All patients were diagnosed with burn scars of the face and body, which were used as the main criteria for inclusion in the study. Exclusion criteria: other types of scars, previous correction of scars using a physiotherapeutic method, general contraindications to laser therapy. Results. The study showed the high efficacy and safety of this method for 112 patients. The dynamics of changes was assessed by the DLQI (The Dermatology Life Quality Index) and DSSI and special (ultrasound scanning, photography) diagnostic methods. The follow-up period ranged from 3 to 7 months. The patients underwent from 2 to 6 laser procedures on the face and body with an interval of 1 month. The study is prospective and planned to be continued. At this point, outputs are presented. During the course of laser procedures, 13 patients dropped out, and 99 continue treatment. Conclusions. The use of the Er:YAG laser with the SMA module for the correction of burn scars allows expanding the possibilities for improving the appearance of the scar with minimal risks of additional hyperpigmentation and stimulation of scar tissue growth.
Pharmateca. 2021;28(14):74-82
pages 74-82 views

Evaluation of the HBD-2 and TLR2 gene expression in the skin of acne patients during combined treatment

Kolodiy A.A., Gryazeva N.V.

Abstract

Background. Not only risk factors such as androgenic stimulation, follicular hyperkeratosis, inflammation and activation of Cutibacterium acnes, but also the activation of innate and adaptive immunity are of great importance in the development of acne. An important role in the immunogenesis of acne belongs to interleukin-1 and a number of other cytokines; however, the literature sources indicate a number of conflicting data on the characteristics of the immune system during the development of various clinical forms of acne. Objective. Evaluation of the HBD-2 and TLR2 gene expression in the skin of patients with acne before treatment and assessment of the effect of the combined use of low doses of isotretinoin and phototherapy with broadband light with a wavelength of440-950 nm on the expression of these genes compared with therapy with standard doses of isotretinoin. Methods. 78 patients diagnosed with moderate papulopustular acne were followed-up in outpatient settings. By the method of simple randomization, 78 patients were divided into 2 groups depending on the method of therapy. These 2 groups were divided into 2 age subgroups: 12-24 years old (subgroups A1 and A2) and 25-45 years old (B1 and B2). The study evaluated the expression levels of the TLR2 and HBD-2 genes in the skin of acne patients before and after treatment and analyzed the results. Results. Decrease in the HBD-2 expression in the skin, an increase in the TLR2 level and the normalization of these parameters after treatment in patients with acne indicate their important role in the pathogenesis of this disease. Conclusion. Thus, the expression of defensin HBD-2 and TLR2 recognition receptor in the skin plays an important role in the pathogenesis of acne.
Pharmateca. 2021;28(14):83-86
pages 83-86 views

Issues of long-term use of antihistamines

Kruglova L.S., Tataurschikova N.S., Tipaeva E.V.

Abstract

Background. Second-generation antihistamines (are the drugs of choice in the treatment of patients with chronic urticaria (induced, spontaneous); furthermore, long-term therapy with antihistamines is required in most cases. For long-term use of antihistamines, the safest ones should be preferred. These include cetirizine and levocetirizine, which have been shown to be safe in numerous placebo-controlled studies. Methods. The study included 27 patients with chronic urticaria. All patients received levocetirizine at a dose of 5 mg per day. To assess the effectiveness of therapy, the Urticaria Activity Score 7 (UAS7) and the Quality of Life Index were used. Results. In 23 (85.2%) patients, levocetirizine was effective with complete disease control. Long-term use of the drug for 12-18 months did not reveal significant side effects that required its withdrawal. Conclusion. The results of an observational study showed the high efficacy and safety of levocetirizine in patients with various forms of chronic urticaria in a standard dosage (5 mg per day) for 12-18 months.
Pharmateca. 2021;28(14):87-93
pages 87-93 views

Comparative analysis of dynamic clinical and dermatoscopic characteristics of single and multiple nevi in patients with risk factors for malignant melanoma

Vakhitova I.I., Michenko A.V., Titov K.S., Brazhnikov A.Y., Romanov D.V.

Abstract

Background. Currently, the benefits of dynamic clinical and dermatoscopic follow-up of patients with multiple melanocytic nevi and high risk for melanoma development are widely discussed. Long-term follow-up for patients with a history of melanoma is recommended in a number of international and domestic clinical guidelines for the diagnosis and treatment of this malignant skin tumor. On the other hand, there are practically no data on the management tactics and frequency of observations for patients with single melanocytic nevi, which may have a potential risk of developing malignant melanoma. Objective. Comparison of the frequency of detection of clinical and dermatoscopic changes in single and multiple nevi in patients with a high risk of developing malignant melanoma. Methods. The dynamic follow-up program included 75 patients with one or more risk factors for the development of malignant melanoma, distributed in group I - 43 patients (50 or more melanocytic nevi) and in group II - 32 patients (<50 melanocytic nevi). The patients underwent a questionnaire survey, a clinical dermatological examination, and double photo-mapping with an observation interval of at least 2 months. If significant dermatoscopic changes were detected, an excisional diagnostic biopsy with histological examination was performed. When clinical or dermatoscopic signs suspicious of melanoma were detected, the diagnosis was verified in the settings of an oncological institution. Results. During the follow-up period, out of 9676 studied melanocytic neoplasms in group I, 473 (4.89%) had dynamic dermatoscopic changes, of which 60 (12.7%) were removed with subsequent pathomorphological examination. In group II, 122 (9.58%) of 1274 melanocytic neoplasms changed during dermatoscopic monitoring. Five (4.1%) lesions out of 122 with clinical and dermatoscopic changes were excised for pathomorphological verification of the diagnosis. The proportion of histologically verified melanomas among neoplasms with significant dermatoscopic changes in patients with single nevi was 40%, in patients with multiple nevi - 9.1%. Conclusion. It was found that in patients with single melanocytic nevi and risk factors for the development of melanoma, dynamic changes in dermatoscopic structures in melanocytic nevi were detected no less frequently than in patients with multiple melanocytic nevi (P=0.022). The necessity of including patients with single melanocytic nevi and risk factors in dynamic dermatoscopic follow-up was substantiated.
Pharmateca. 2021;28(14):94-100
pages 94-100 views

Management of gerontological patients with dermatological diseases

Markelova E.M.

Abstract

This review article presents up-to-date information on the nature of distribution and currently existing modern methods of treating various dermatological diseases in elderly patients in the Central Russia. It is emphasized that the significant socio-economic and medical burden of oncological diseases in elderly patients requires certain cancer alertness from doctors of various specialties. In addition, it is necessary to implement a personalized approach to the treatment of dermatoses in gerontological patients, taking into account the data of medical history and comorbid pathology.
Pharmateca. 2021;28(14):102-105
pages 102-105 views

Dermatoses in elderly diabetic patients

Ladygina D.O., Zheleznyakova A.V.

Abstract

Diabetes mellitus (DM) is a common chronic age-associated disease, which is becoming a non-infectious epidemic worldwide, and affects many organs, including the skin. Diabetic patients can have completely different dermatological manifestations, which differ in severity, pathogenesis, and degree of manifestation. The article presents data on the most common dermatoses in elderly diabetic patients; identifies the main links of their pathogenesis and diagnostic methods. Considering the fact that skin lesions in elderly diabetic patients can cause certain difficulties in diagnosis and choice of therapeutic tactics, the features of treatment and the need to combine the efforts of doctors of various specialties (endocrinologist, dermatologist, surgeon, allergologist, gerontologist) to achieve the goal of treatment are discussed.
Pharmateca. 2021;28(14):106-111
pages 106-111 views

Are the goals of psoriasis treatment achievable in real clinical practice?

Kruglova L.S., Khotko A.A., Rudneva N.S.

Abstract

Severe forms of psoriasis are very often associated with comorbid pathology. At the same time, comorbid pathology aggravates the course of psoriasis and reduces the effectiveness of therapy, in particular, with disease-modifying and biological drugs. In many patients with comorbid pathology, only biological therapy drugs can be used as therapy for severe psoriasis due to relative contraindications for other drugs for systemic therapy of psoriasis. Psoriatic patients with comorbid pathology should be managed by dermatologists and related specialists: endocrinologists, cardiologists, nutritionists, physiotherapy specialists to correct conditions that worsen the course of psoriasis and negatively affect the therapeutic effect of systemic drugs. The drug guselkumab is actively introduced into the practice of dermatovenerologists for the treatment of moderate and severe psoriasis. The presented clinical cases demonstrate the high efficacy of guselkumab in patients with comorbid pathology, as well as in achieving PASI90 and PAS1100 in patients with severe psoriasis. The treatment was well tolerated; no adverse events were found during therapy. The data of clinical studies and practical experience of use determine the choice of guselkumab as a drug with the best efficacy profile for the current period, a stable safety profile and the possibility of using in patients with combined comorbid pathology.
Pharmateca. 2021;28(14):112-119
pages 112-119 views

Miescher’s granulomatous cheilitis or delayed inflammatory edema of the upper lip after filler injection: difficulties in differential diagnosis

Ikonnikova E.V., Kruglova L.S., Manturova N.E., Shchekochikhin V.A.

Abstract

Background. Granulomatous cheilitis (GC) is a chronic granulomatous inflammation of the lips (usually the upper one), accompanied by non-pitting diffuse painless edema. This disease can occur in the form of a monosymptomatic form (Miescher’s syndrome) or be part of the Melkersson-Rosenthal syndrome triad (granulomatous cheilitis, facial paralysis, folded tongue). The disease is rare, and the etiology remains unknown. Description of the clinical case. This article presents a clinical case of GC in a 50-year-old female patient, who was followed up by a beautician for a long time with a presumptive diagnosis of delayed inflammatory edema of the upper lip after filler injection. Conclusion. This clinical case is of interest to doctors of various specialties due to the need for interdisciplinary interaction for the timely diagnosis, observation and treatment of such patients.
Pharmateca. 2021;28(14):120-123
pages 120-123 views

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies